Trial · NCT07883616
Modified Thoracolumbar Interfascial Plane Block vs Retrolaminar Block for Pain in Lumbar Spine Surgeries
NCT07883616, Not applicable, Recruiting, Zagazig University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Modified Thoracolumbar Interfascial Plane Block vs Retrolaminar Block for Pain in Lumbar Spine Surgeries. Trials, record NCT07883616. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07883616
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Modified Thoracolumbar Interfascial Plane Block vs Retrolaminar Block for Pain in Lumbar Spine Surgeries
- NCT number
- NCT07883616
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 42 participants, estimated
- Lead sponsor
- Zagazig University
- Conditions
- Postoperative Pain After Spinal Surgery
- Interventions
- Morphine, Bupivacaine, Dexamethasone, Magnesium Sulphate, Modified Thoracolumbar Interfascial Plane Block, Retrolaminar Block
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total morphine consumption in the first 24 hours postoperatively | 24 hours postoperatively | Cumulative morphine dose (mg) administered as rescue analgesia during the first 24 postoperative hours |
| Secondary | Pain intensity by Numerical Rating Scale (NRS) | At 2, 4, 8, 12, 18, and 24 hours postoperatively | Pain intensity assessed using a 10-point Numerical Rating Scale (0 = no pain, 10 = worst pain imaginable) |
| Secondary | Time to first rescue analgesia | First 24 hours postoperatively | Time from local anesthetic injection until the patient first requests additional pain-relieving medication (NRS \> 3) |
| Secondary | Block performance time | During block procedure | Time required to perform the block procedure |
| Secondary | Onset of sensory block | Within 20-30 minutes after injection | Time from local anesthetic injection until loss of sensation in the desired dermatomes |
| Secondary | Opioid-related side effects | 24 hours postoperatively | Incidence of postoperative nausea and vomiting (PONV) assessed by PONV impact scale (0 = none, 1 = mild, 2 = moderate, 3 = severe), sedation, and respiratory depression |
| Secondary | Patient satisfaction score | 24 hours postoperatively | Patient satisfaction assessed using a 4-point scale (4 = excellent, 3 = good, 2 = fair, 1 = poor) |
| Secondary | Incidence of chronic pain | 3 to 6 months postoperatively | Chronic pain will be assessed at 3 months postoperatively via a structured follow-up (telephone interview or outpatient clinic visit). Patients will be asked whether they experience persistent or recurrent pain at or around the surgical site lasting more than 3 months after surgery. Responses will be recorded as "Yes" or "No," and the proportion of patients answering "Yes" will be reported as the incidence of chronic pain, according to the IASP definition (pain persisting or recurring for more than 3 months). |
| Secondary | Time of ambulation | First 24 hours postoperatively | Time to first mobilization after surgery |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers6
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07883616
GET https://conductscience.org/api/trials/v1/NCT07883616/registered